Systems Oncology Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Series B
- Investors
-
2
Systems Oncology General Information
Description
Developer of cancer treatment drugs designed to accelerate scientific innovations into breakthrough cancer therapies. The company's drugs are created by utilizing advanced cognitive computing technologies to mine big data for hidden biomedical insights, integrating big-data aggregation and mechanistic analysis, enabling researchers to identify novel therapeutic opportunities, accelerate drug discovery, and improve patient outcomes.
Contact Information
Website
www.systemsoncology.comCorporate Office
- 7201 East Henkel Way
- Suite 205
- Scottsdale, AZ 85255
- United States
Corporate Office
- 7201 East Henkel Way
- Suite 205
- Scottsdale, AZ 85255
- United States
Systems Oncology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series B) | 22-Oct-2019 | Completed | Generating Revenue | |||
| 1. Early Stage VC | Completed | Startup |
Systems Oncology Patents
Systems Oncology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3217459-A1 | Compositions for inhibiting growth of targeted cells | Pending | 06-May-2021 | ||
| US-20240229033-A1 | Compositions for inhibiting growth of targeted cells | Pending | 06-May-2021 | ||
| WO-2022235971-A2 | Compositions for inhibiting growth of targeted cells | Inactive | 06-May-2021 | ||
| WO-2022235971-A3 | Compositions for inhibiting growth of targeted cells | Inactive | 06-May-2021 | ||
| WO-2022235971-A9 | Compositions for inhibiting growth of targeted cells | Inactive | 06-May-2021 | C12N15/113 |
Systems Oncology Signals
Systems Oncology Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| The Pritzker Organization | Merchant Banking Firm | Minority | ||
| Lakeshore Capital Partners | Growth/Expansion | Minority |
Systems Oncology FAQs
-
When was Systems Oncology founded?
Systems Oncology was founded in 2015.
-
Where is Systems Oncology headquartered?
Systems Oncology is headquartered in Scottsdale, AZ.
-
What is the size of Systems Oncology?
Systems Oncology has 12 total employees.
-
What industry is Systems Oncology in?
Systems Oncology’s primary industry is Drug Discovery.
-
Is Systems Oncology a private or public company?
Systems Oncology is a Private company.
-
What is Systems Oncology’s current revenue?
The current revenue for Systems Oncology is .
-
Who are Systems Oncology’s investors?
The Pritzker Organization and Lakeshore Capital Partners have invested in Systems Oncology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process